Fol. Biol. 2006, 52, 190-193
https://doi.org/10.14712/fb2006052060190
Preliminary Report of Expression of bax in Oral Cavity Pathologies
References
1. , F., Brousset, P., Krajewski, S., Schlaifer, D., Selves, J., Reed, J. C., Caron P. (1996) Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland. J. Clin. Endocrinol. Metab. 81, 2726-2730.
2. , P, Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162, 156-159.
<https://doi.org/10.1016/0003-2697(87)90021-2>
3. , S. D., Marcovitch, A. J., Johnson, D. E., Melhem, M. F., Tweardy, D. J., Grandis, J. R. (2001) Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium. J. Oral Pathol. Med. 30, 309-315.
4. , J., Zhang, L., Huang, X., Lin, T., Yin, M., Xu, M., Ji, L., Roth, J. A., Fang, B. (2002) A novel single tetracyclineregulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. Oncogene 21, 4757-4764.
<https://doi.org/10.1038/sj.onc.1205582>
5. , W., Yu, S., Gao, Y. (1997) Expression of apoptosisrelated protein in epithelial dysplasia and squamous cell carcinoma. Oral Oncol. 33, 419-425.
6. , W. K., Gomez-Navarro, J., Arafat, W. O., Xiang, J., Mahasrehti, P. J., Alvarez, R. O., Barnes, M. N., Curiel, D. T. (2001) Bax-induced apoptosis as a novel gene therapy approach for carcinoma of the cervix. Gyn. Oncol. 83, 370-377.
<https://doi.org/10.1006/gyno.2001.6403>
7. , J. J., Parslow, T. G. (1996) A peptide sequence from bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem. 271, 8521-8524.
<https://doi.org/10.1074/jbc.271.15.8521>
8. , R. C., Catzavelos, G. C., Barrett, A. W., Speight, P. M. (2003) Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Pol. J. Pathol. 54, 49-52.
9. , T., Sawa, H., Morikawa, J., Zhang, W., Shiku H. (2000) Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells. Jpn. J. Cancer Res. 91, 1264.
<https://doi.org/10.1111/j.1349-7006.2000.tb00913.x>
10. , M., Krajewski, S., Epstein, J. I., Shabaik, A., Sauvageot, J., Song, K., Kitada, S., Reed, J. C. (1996) Immunohistochemical analysis of bcl-2, bax, bcl-x and mcl-1 expression in prostate cancers. Am. J. Pathol. 148, 1567-1576.
11. , H., Ooya, K. (1997) Immunohistochemical analysis of bcl-2 family proteins in benign and malignant ameloblastomas. J. Oral Pathol. Med. 26, 419-425.
<https://doi.org/10.1111/j.1600-0714.1997.tb00242.x>
12. , X., Marani, M., Yu, J., Nan, B., Roth, J. A., Kagawa, S., Fang, B., Denner, L., Marcelli, M. (2001) Adenovirusmediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Cancer Res. 61, 186-191.
13. , L. L, Vintermyr, O. K., Liavaag, P. G., Jonsson, R., Johannessen, A. C. (2002) Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis. Oral Oncol. 38, 691-698.
<https://doi.org/10.1016/S1368-8375(02)00002-7>
14. , S. L., Rubinchik, S., Honda, T., McDonnell, T. J., Dong, J. Y., Norris, J. S. (2001) Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNcaP prostate cancer cells. Gene Ther. 8, 1363.
<https://doi.org/10.1038/sj.gt.3301531>
15. , E., Senzaki, H., Yamamoto, D., Yoshida, R., Takada, H., Hioki, K., Tsubura, A. (1999) Prognostic significance of Bcl-2, Bcl-xL/S, Bax, Bak expressions in colorectal carcinomas. Oncol. Rep. 6, 365-369.
16. , E. C., Nassirpour, R., Yang, M., Wang, J., Nardin, S. R., Gu, J., Fang, B., Moossa, A. R., Hoffman, R. M., Bouvet, M. (2002) Bax-induction gene therapy of pancreatic cancer. J. Surg. Res. 106, 346-351.
<https://doi.org/10.1006/jsre.2002.6473>
